“In general, if it suddenly comes to the development of the most negative scenario with supply restrictions, then China will relatively easily replace 90 percent of all pharmaceutical raw materials,” RIA Novosti quotes Bespalov.
He noted that more than 75% of the supply of pharmaceutical raw materials in volume terms falls on China and India, among European countries France and the Netherlands are in the lead.
Earlier it was reported that the Ministry of Health of Russia receives separate signals about delays in the supply of medicines, which is associated with logistical problems, and not with plant failures.
Elena Nevolina, Executive Director of the non-profit partnership Pharmacy Guild, commented on the situation with medicines in an interview with the 360 TV channel.